METAOD005: A Phase IIb (randomized, double-blind, placebo-controlled) study to assess the efficacy (reduction in body weight), safety and tolerability of 12 weeks treatment with daily doses (1, 5, 10, 20 or 30 mg AOD9604) administered orally (capsules) in 300 healthy, clinically obese males, and females of non-child bearing potential, with a BMI 35 kg/m 2
Alcohol also throws off your bodys electrolyte balance
Better still, if you know you will be on 0.25mg for four weeks and then 0.5mg for the next four weeks, you can plan your reconstitution date so that the 28-day window covers both titration steps
However, its important to consult with a healthcare provider to fully understand the potential risks and benefits, especially if other underlying conditions, such as diabetes or autoimmune disorders, are present